Lareb Database

OMEPRAZOL

  Attention: The results shown, apply for the ATC-group of drugs to which OMEPRAZOL belongs. Click here for a complete overview of these drugs.

Click for more information about:

Publications Lareb

Publications, both in English and in Dutch, by the Netherlands Pharmacovigilance Centre Lareb

# Author(s) Title Magazine Year Volume Link
1 Blokpoel R.G.T., .Broos N, de Jong-van den Berg L.T.W., de Vries T.W Waarde omeprazol bij huilende zuigelingen beperkt Nederlands Tijdschrift voor Geneeskunde 2010 154:A1850 Download publication

2 van Hunsel F, de Jong L, de Vries T (es)omeprazole and discoloration of regurgitated gastric contents in infants; worrying for care-takers and sign of a reduced bioavailability The Journal of Paediatric Pharmacology and Therapeutics 2016 21 DOI
3 Weits G Omeprazol en verkleurd sputum bij zuigelingen Uitsluitend Apotheek (UA) 2017 7 Download publication

4 Sonnenberg M., Weits,G Paars speeksel, spuug of braaksel bij (es)omeprazol Pharmaceutisch Weekblad 2019 154 Download publication

5 van Es M Omeprazol-suspensie Pedippi: moeilijk door te slikken voor jonge kinderen Uitsluitend Apotheek (UA) 2022 12 Download publication

Signals

Signals as submitted to Lareb to the Dutch Medicines Evaluation Board. Some of the articles are in Dutch only.

# Title Year Download
1 Omeprazole and erectile dysfunction - an update 2015 Signals document

2 Proton pump inhibitors and tongue discolouration 2010 Signals document

3 Meldingen na substitutie omeprazol naar Omecat® 2017 Signals document

4 Omeprazole and coumarine interactions 2010 Signals document

5 Omeprazole and discolouration of the gastric content 2014 Signals document

Overview of reports submitted to Lareb

To ensure a correct interpretation of the results, the data shown may only be used for publications or other media after consulting Lareb. Please read the disclaimer.

The reports shown on this website were received directly by the Netherlands Pharmacovigilance Centre Lareb. If you enter a brand name or generic name, all reports of products will be shown that contain the corresponding active substance. The selection that is shown is based on the ATC classification system of the World Health Organization.

The fact that a possible side effect of a drug or vaccine is reported, does not imply that the reported symptoms are actually caused by the drug or vaccine. Since the aim of a voluntary reporting centre is to detect new adverse drug reactions, we ask healthcare professionals and consumers to report suspicions of ADRs, even if the causal relationship has not been proven.

One single report may refer to multiple ADRs For this reason, the number of reports may be higher than the number of reports shown in the overview.

The number of reports shown does not necessarily reflect the actual change for an ADR to occur. It is therefore not possible to calculate an incidence rate of these ADRs based on these data.

Most recent update: 1/24/2023.

OMEPRAZOL

Number of reports 2,544
Serious 274
Gender
Male
Female
Unknown
1,016
(40%)
1,520
(60%)
8
(0%)
Age
 
Year received
Calender year of reporting.
 
Year ADR
Calender year in which the possible ADR occured. If more events have been reported, the year in which the first event occurred is shown. Before 2002 the date, on which the report was received, was noted instead of the date of occurrence of the possible adverse drug reaction. For these reports the year in which the reaction actually occurred is not always known.
 
Reporter
 

Overview of reported side effects

Click on a side effect for more specific information

Blood and lymphatic system : 24
Leukopenia : 6
Neutropenia : 1
Autoimmune haemolytic anaemia : 1
Anaemia : 2
Iron deficiency anaemia : 3
Coagulopathy : 1
Pernicious anaemia : 1
Thrombocytopenia : 6
Lymphadenopathy : 1
Agranulocytosis : 1
Polycythaemia : 1
Cardiac : 58
Angina pectoris : 2
Cardiac disorder : 4
Palpitations : 40
Atrial fibrillation : 4
Arrhythmia : 2
Tachycardia : 3
Bradycardia : 2
Ventricular tachycardia : 1
Ear and labyrinth : 65
Deafness : 3
Vertigo : 10
Ear pain : 1
Tinnitus : 39
Ear swelling : 1
Hypoacusis : 11
Endocrine system : 6
Hypoparathyroidism : 2
Thyroid disorder : 2
Inappropriate antidiuretic hormone secretion : 1
Hypothyroidism : 1
Eye : 138
Retinal disorder : 1
Blindness : 1
Dry eye : 2
Diplopia : 6
Visual field defect : 1
Visual impairment : 32
Uveitis : 1
Eye pruritus : 1
Blepharospasm : 2
Photophobia : 3
Retinal detachment : 1
Amblyopia : 1
Macular degeneration : 1
Ocular discomfort : 1
Eye disorder : 2
Eye haemorrhage : 1
Eye irritation : 6
Eyelid oedema : 1
Eye inflammation : 1
Eye pain : 3
Eye swelling : 3
Eyelid ptosis : 1
Ocular hyperaemia : 2
Visual acuity reduced : 1
Photopsia : 2
Lacrimation increased : 1
Lacrimation disorder : 2
Periorbital oedema : 1
Vision blurred : 56
Swelling of eyelid : 1
Gastrointestinal : 1110
Haemorrhoids : 1
Gastrointestinal disorder : 9
Oesophageal disorder : 1
Abnormal faeces : 6
Aphthous ulcer : 10
Pancreatitis : 4
Anal pruritus : 3
Salivary duct obstruction : 1
Oral mucosal blistering : 8
Haematemesis : 1
Haematochezia : 5
Rectal haemorrhage : 1
Oesophageal ulcer haemorrhage : 1
Eructation : 31
Vomiting : 57
Glossodynia : 8
Gastric haemorrhage : 1
Abdominal discomfort : 48
Abdominal pain : 77
Burning mouth syndrome : 1
Dental caries : 1
Diarrhoea : 106
Discoloured vomit : 4
Dry mouth : 62
Duodenogastric reflux : 1
Epigastric discomfort : 2
Oral mucosal erythema : 1
Frequent bowel movements : 3
Dysphagia : 14
Swollen tongue : 9
Anal incontinence : 1
Infrequent bowel movements : 2
Intrinsic factor deficiency : 1
Anal fissure : 1
Oesophageal spasm : 2
Tongue geographic : 1
Lip dry : 2
Lip disorder : 2
Lip haemorrhage : 1
Lip swelling : 13
Gastric disorder : 4
Gastrointestinal pain : 9
Gastrointestinal sounds abnormal : 2
Dyspepsia : 83
Gastritis : 2
Gastric polyps : 5
Nausea : 181
Oral disorder : 1
Constipation : 40
Oedema mouth : 1
Oesophageal pain : 2
Stomatitis : 23
Colitis : 1
Uvulitis : 1
Oesophagitis : 2
Cheilitis : 2
Breath odour : 2
Abdominal distension : 32
Oral discomfort : 4
Oral mucosal eruption : 1
Abdominal pain upper : 74
Proctalgia : 1
Oral pain : 3
Abdominal pain lower : 1
Irritable bowel syndrome : 1
Rebound acid hypersecretion : 1
Regurgitation : 1
Odynophagia : 2
Oesophageal discomfort : 1
Salivary gland calculus : 1
Tooth disorder : 4
Toothache : 3
Paraesthesia oral : 4
Tongue dry : 1
Tongue disorder : 4
Tongue movement disturbance : 2
Tongue oedema : 5
Glossitis : 6
Tongue discomfort : 2
Tongue erythema : 1
Tongue discolouration : 9
Change of bowel habit : 2
Saliva altered : 1
Salivary hypersecretion : 2
Faeces discoloured : 6
Gastrointestinal motility disorder : 1
Steatorrhoea : 2
Flatulence : 52
Gastrooesophageal reflux disease : 14
Melaena : 1
Mouth ulceration : 1
General disorders and administr. Site : 777
Atrophy : 1
Thirst : 4
Localised oedema : 1
Drug ineffective : 53
Adverse drug reaction : 1
Drug interaction : 35
Drug withdrawal syndrome : 2
Feeling abnormal : 6
Sensation of foreign body : 2
Face oedema : 3
Influenza like illness : 3
Feeling hot : 2
Feeling cold : 3
Hunger : 2
Crying : 1
Inhibitory drug interaction : 3
Injection site haematoma : 1
Injection site warmth : 1
Injection site pruritus : 3
Hangover : 1
Pyrexia : 21
Chills : 13
Moaning : 1
Asthenia : 12
Gait disturbance : 9
Malaise : 52
Oedema : 8
Axillary pain : 1
Chest discomfort : 7
Inflammation : 1
Injection site inflammation : 2
Withdrawal syndrome : 3
Therapeutic response unexpected : 238
Oedema peripheral : 34
Peripheral swelling : 6
Pain : 8
Chest pain : 20
Injection site pain : 3
Potentiating drug interaction : 12
Application site reaction : 1
Injection site erythema : 3
Screaming : 1
Secretion discharge : 1
Mucosal pain : 1
Mucosal disorder : 1
Mucosal dryness : 1
Rebound effect : 3
Therapeutic product effect incomplete : 1
Therapeutic product effect decreased : 20
Therapeutic product ineffective : 1
Therapeutic response decreased : 62
Fatigue : 83
Condition aggravated : 5
Food interaction : 1
Feeling drunk : 1
Feeling jittery : 2
Swelling : 3
Swelling face : 5
Injection site swelling : 2
Hepatobiliary : 31
Hepatic function abnormal : 6
Jaundice : 3
Jaundice cholestatic : 2
Hepatitis toxic : 3
Hepatitis : 7
Hepatitis cholestatic : 2
Hepatocellular injury : 1
Liver disorder : 3
Hepatic failure : 2
Hepatic pain : 1
Hepatotoxicity : 1
Immune system : 32
Serum sickness : 1
Anaphylactic reaction : 7
Anaphylactic shock : 11
Drug hypersensitivity : 1
Hypersensitivity : 9
Anaphylactoid reaction : 2
Reaction to excipient : 1
Infections and infestations : 31
Tonsillitis : 1
Cystitis : 1
Mastitis : 1
Respiratory tract infection : 1
Campylobacter gastroenteritis : 1
Oesophageal candidiasis : 1
Candida infection : 1
Herpes zoster : 3
Infection : 1
Infection susceptibility increased : 1
Laryngitis : 1
Rhinitis : 1
Sialoadenitis : 2
Conjunctivitis : 5
Oral candidiasis : 3
Pseudomembranous colitis : 1
Pustule : 1
Rash pustular : 1
Fungal infection : 2
Parotitis : 1
Urinary tract infection : 1
Injury and poisoning : 10
Subdural haematoma : 1
Hip fracture : 1
Maternal exposure during pregnancy : 4
Eye contusion : 1
Overdose : 1
Toxicity to various agents : 1
Fall : 1
Investigations : 117
Apgar score low : 1
Blood iron decreased : 1
Blood urine present : 1
Blood magnesium decreased : 2
Blood pressure diastolic increased : 1
Blood pressure increased : 3
Blood pressure decreased : 5
Bleeding time prolonged : 1
Blood calcium decreased : 1
Blood creatinine increased : 1
Gamma-glutamyltransferase increased : 1
Weight increased : 32
Weight decreased : 8
Blood glucose increased : 3
Heart rate irregular : 1
Heart rate increased : 5
Heart rate decreased : 1
Haemoglobin decreased : 4
International normalised ratio increased : 10
Blood potassium decreased : 2
Hepatic enzyme increased : 4
Liver function test abnormal : 6
Body temperature increased : 3
Body temperature decreased : 2
Gastric pH increased : 1
Sputum abnormal : 1
Drug level increased : 2
Urine analysis abnormal : 1
Transaminases increased : 1
Alanine aminotransferase increased : 4
Urine output decreased : 2
Oxygen saturation decreased : 1
Coagulation time shortened : 1
Vitamin B12 decreased : 1
Vitamin B6 increased : 1
Blood glucose fluctuation : 2
Metabolism and nutrition : 239
Tetany : 3
Abnormal loss of weight : 1
Food aversion : 1
Diabetes mellitus : 3
Folate deficiency : 1
Lack of satiety : 1
Vitamin B12 deficiency : 11
Weight fluctuation : 1
Hyperglycaemia : 6
Hyperlactacidaemia : 1
Alkalosis hypochloraemic : 1
Gout : 4
Hypoglycaemia : 4
Hypocalcaemia : 32
Hypophosphataemia : 2
Hypokalaemia : 28
Hypomagnesaemia : 92
Hyponatraemia : 4
Increased appetite : 8
Hyperphosphataemia : 1
Decreased appetite : 20
Appetite disorder : 2
Electrolyte imbalance : 2
Ketoacidosis : 1
Vitamin D deficiency : 2
Fluid retention : 5
Zinc deficiency : 1
Obesity : 1
Musculoskeletal and connective tissue : 300
Muscle atrophy : 1
Osteoarthritis : 1
Bone pain : 3
Bone swelling : 1
Rhabdomyolysis : 1
Arthropathy : 1
Arthritis : 3
Polyarthritis : 1
Arthralgia : 56
Joint stiffness : 1
Joint swelling : 2
Trismus : 1
Musculoskeletal discomfort : 2
Groin pain : 1
Myopathy : 2
Neck pain : 1
Osteoporosis : 6
Tendon pain : 2
Pain in extremity : 12
Flank pain : 3
Pain in jaw : 3
Limb discomfort : 4
Rheumatic disorder : 1
Rheumatoid arthritis : 1
Back pain : 11
Musculoskeletal chest pain : 1
Musculoskeletal pain : 6
Musculoskeletal stiffness : 6
Muscle discomfort : 1
Myalgia : 100
Muscle spasms : 36
Muscle twitching : 2
Muscular weakness : 25
Osteopenia : 1
Osteonecrosis : 1
Neoplasms : 4
Bladder cancer : 1
Rectal cancer : 1
Gastric cancer : 1
Renal neoplasm : 1
Nervous system : 624
Disturbance in attention : 8
Cerebrovascular accident : 1
Loss of consciousness : 4
Burning sensation : 2
Burning sensation mucosal : 2
Dementia : 3
Vascular dementia : 1
Dementia Alzheimer's type : 1
Head discomfort : 6
Dizziness : 156
Epilepsy : 1
Serotonin syndrome : 1
Balance disorder : 9
Facial spasm : 1
Syncope : 12
Memory impairment : 8
Amnesia : 1
Facial paresis : 2
Cerebral haemorrhage : 1
Cerebral disorder : 1
Headache : 164
Dizziness postural : 2
Transient ischaemic attack : 1
Migraine : 14
Hypogeusia : 1
Monoparesis : 1
Neurological symptom : 1
Anosmia : 3
Optic neuritis : 1
Muscle contractions involuntary : 3
Hyperaesthesia : 2
Peripheral motor neuropathy : 1
Neuropathy peripheral : 3
Polyneuropathy : 2
Presyncope : 2
Restless legs syndrome : 4
Sedation : 2
Somnolence : 35
Taste disorder : 12
Ageusia : 13
Speech disorder : 4
Dysarthria : 1
Aphasia : 2
Sensory disturbance : 2
Paraesthesia : 54
Stupor : 1
Seizure : 6
Tremor : 15
Parosmia : 6
Convulsive threshold lowered : 1
Hypertonia : 2
Paralysis : 1
Depressed level of consciousness : 1
Hypoaesthesia : 5
Dysaesthesia : 1
Dysgeusia : 29
Neuralgia : 4
Parkinson's disease : 1
Pregnancy and perinatal conditions : 3
Haemorrhage in pregnancy : 1
Foetal growth restriction : 1
Abortion spontaneous : 1
Product issues : 34
Product physical consistency issue : 11
Product taste abnormal : 1
Product complaint : 8
Product blister packaging issue : 2
Product colour issue : 1
Product quality issue : 1
Product substitution issue : 9
Product counterfeit : 1
Psychiatric : 232
Adjustment disorder with depressed mood : 1
Abnormal behaviour : 1
Abnormal dreams : 6
Paranoia : 1
Aggression : 11
Alcoholism : 1
Anxiety : 9
Apathy : 3
Enuresis : 2
Compulsive lip biting : 1
Compulsive cheek biting : 1
Depersonalisation/derealisation disorder : 1
Depression : 12
Depressed mood : 23
Derealisation : 2
Disorientation : 1
Emotional disorder : 2
Self-injurious ideation : 1
Hallucination : 11
Anorgasmia : 1
Hallucination, auditory : 2
Delirium : 3
Initial insomnia : 1
Reading disorder : 1
Listless : 5
Nightmare : 2
Obsessive-compulsive disorder : 1
Agitation : 8
Panic attack : 2
Panic reaction : 2
Personality change : 1
Irritability : 4
Mental disorder : 3
Psychomotor retardation : 1
Psychotic disorder : 1
Restlessness : 10
Poor quality sleep : 4
Sleep attacks : 1
Sleep disorder : 18
Insomnia : 46
Mood swings : 3
Dysphemia : 1
Depressive symptom : 1
Bruxism : 1
Libido decreased : 3
Confusional state : 10
Delusion : 1
Suicidal ideation : 4
Nervousness : 1
Renal and urinary tracts : 69
Micturition disorder : 3
Renal disorder : 1
Acute kidney injury : 1
Bladder pain : 2
Haematuria : 2
Nocturia : 1
Renal failure : 7
Renal impairment : 9
Renal colic : 1
Nephritis : 3
Renal pain : 1
Dysuria : 3
Tubulointerstitial nephritis : 22
Urine odour abnormal : 1
Urinary incontinence : 3
Urge incontinence : 2
Urinary retention : 1
Calculus urinary : 1
Polyuria : 1
Pollakiuria : 2
Chromaturia : 2
Reproductive system and breasts : 107
Vulval disorder : 1
Vulvovaginal discomfort : 1
Haematospermia : 1
Postmenopausal haemorrhage : 1
Breast cyst : 1
Breast hyperplasia : 1
Breast pain : 3
Breast enlargement : 5
Genital rash : 1
Genital haemorrhage : 1
Breast swelling : 1
Heavy menstrual bleeding : 1
Erectile dysfunction : 24
Pruritus genital : 2
Galactorrhoea : 1
Menstrual disorder : 3
Menstruation irregular : 1
Penis disorder : 2
Breast tenderness : 1
Nipple disorder : 1
Nipple pain : 1
Endometrial hyperplasia : 1
Ejaculation failure : 2
Vaginal discharge : 1
Vulvovaginal dryness : 1
Gynaecomastia : 45
Vulvovaginal burning sensation : 1
Vulvovaginal pruritus : 1
Amenorrhoea : 1
Respiratory and thoracic : 203
Asphyxia : 2
Asthma : 1
Throat tightness : 1
Epistaxis : 9
Diaphragmatic disorder : 2
Dry throat : 6
Nasal dryness : 1
Pharyngeal swelling : 6
Yawning : 2
Suffocation feeling : 1
Hiccups : 4
Cough : 20
Hyperventilation : 4
Interstitial lung disease : 1
Throat irritation : 3
Throat lesion : 1
Dyspnoea : 55
Dyspnoea exertional : 2
Pneumonitis : 1
Respiratory disorder : 3
Nasal discomfort : 1
Nasal congestion : 1
Sneezing : 1
Laryngospasm : 1
Oropharyngeal blistering : 1
Oropharyngeal pain : 18
Wheezing : 2
Productive cough : 2
Reflux laryngitis : 1
Snoring : 2
Sputum increased : 1
Sputum discoloured : 32
Dysphonia : 3
Increased bronchial secretion : 3
Increased upper airway secretion : 1
Aspiration : 1
Choking : 4
Choking sensation : 3
Skin and subcutaneous tissue : 593
Lichenoid keratosis : 1
Acne : 2
Umbilical discharge : 1
Dermatitis allergic : 1
Angioedema : 25
Blister : 7
Pemphigus : 1
Dermatitis contact : 1
Dry skin : 5
Eczema : 8
Ecchymosis : 2
Erythema multiforme : 5
Exfoliative rash : 1
Urticaria : 47
Hair disorder : 1
Alopecia : 97
Dandruff : 1
Lichen planus : 3
Toxic epidermal necrolysis : 4
Fixed eruption : 1
Drug eruption : 1
Skin odour abnormal : 1
Skin mass : 1
Skin irritation : 1
Skin fissures : 1
Dermatitis : 1
Dermatitis bullous : 4
Skin reaction : 2
Rash : 71
Rash maculo-papular : 6
Rash papular : 3
Toxic skin eruption : 2
Rash vesicular : 2
Cutaneous lupus erythematosus : 1
Pruritus : 101
Rash pruritic : 28
Purpura : 6
Hypotrichosis : 1
Night sweats : 8
Nail disorder : 4
Nail growth abnormal : 1
Nail discolouration : 1
Cutaneous vasculitis : 1
Nodular vasculitis : 1
Onychoclasis : 2
Dermatitis acneiform : 1
Hypersensitivity vasculitis : 1
Hyperhidrosis : 43
Seborrhoea : 2
Hyperkeratosis : 1
Papule : 2
Alopecia areata : 3
Psoriasis : 9
Petechiae : 2
Photosensitivity reaction : 10
Rash erythematous : 9
Erythema nodosum : 2
Erythema : 18
Rosacea : 1
Stevens-Johnson syndrome : 1
Subacute cutaneous lupus erythematosus : 3
Skin hyperpigmentation : 2
Trichorrhexis : 1
Hair colour changes : 1
Hair texture abnormal : 3
Madarosis : 1
Skin depigmentation : 1
Skin exfoliation : 8
Chloasma : 1
Sweat discolouration : 1
Cold sweat : 1
Surgical and medical procedures : 1
Cardiac pacemaker insertion : 1
Vascular : 57
Peripheral vascular disorder : 1
Phlebitis : 1
Cyanosis : 1
Pallor : 2
Haematoma : 15
Peripheral ischaemia : 1
Embolism : 1
Circulatory collapse : 2
Peripheral coldness : 3
Hypotension : 4
Hot flush : 6
Flushing : 10
Vasculitis : 1
Hypertension : 9
Overview of reports submitted to EMA
All reports submitted to EMA can be found here.
Overview of reports submitted to World Health Organization

VigiBase® data

This data is sourced from VigiBase, the World Health Organization’s (the “WHO”) global database for suspected adverse drug reactions “ADRs”, maintained by Uppsala Monitoring Centre (“UMC”). UMC is the WHO Collaborating Centre for International Drug Monitoring based in Uppsala, Sweden providing scientific leadership and operative support to the WHO Program for International Drug Monitoring (www.who-umc.org).

The data contains reports of suspected ADRs, so called Individual Case Safety Reports (ICSRs), collected by national drug authorities in over 120 countries and span over more than 100 000 different medicinal products. Thus, this database is only a repository of ICSRs provided for VigiBase, and shall not be considered as a systematic register of ADRs that have occurred or may occur.

The volume of ICSRs for a particular medicinal product may be influenced by many different factors, including but not limited to the extent of use of the product, publicity and the nature of the reactions. No information is provided on the number of patients exposed to a particular product, and it is therefore, based on the ICSRs, not possible to calculate frequency of any ADR. Moreover, collection of data is, due to e.g. differing national legislation and policies, heterogeneous between different countries. For these reasons, any interpretation of ADR data, and particularly those based on comparisons between various medicinal products, may be misleading.

Information on a suspected ADR should not be interpreted as meaning that the medicinal product in question, or the active substance(s), generally causes the observed effect or is unsafe to use. Any robust conclusion with regard to benefits and risks of a specific medicinal product always requires detailed evaluation and scientific assessment of all available data. The balance between benefit and risk of a specific medicinal product also varies between individual patients.

If you think that you may be experiencing a side-effect from a medicinal product, please seek advice from a health professional as soon as possible. Never stop or change the dose for prescription medicines without consulting your physician.

About the release of this data:
UMC takes great care to ensure that the data contained herein is an accurate record of data collected by the national drug authorities and transmitted to UMC. UMC does, however, not guarantee, warrant or make any representation whatsoever regarding the data contained herein, including but not limited to guarantees, warranties or representations of accuracy, reliability, completeness, currency, suitability, fitness or usefulness for any particular purpose or with respect to non-infringement of any third-party rights. In no event shall UMC be liable for any loss, damage, cost or other expense whatsoever (whether direct, indirect, punitive, incidental, special or consequential) arising out of or in any way connected with the use of or reference to any data contained herein. In no event shall UMC be liable other than i) under Swedish substantive law and ii) subject to the courts of Sweden with the district court of Uppsala as first instance.

OMEPRAZOL

Number of reports 131,548
Gender
Female
Male
Unknown
64,497
(49%)
45,027
(34%)
22,024
(17%)
Age
Year received
Region
Africa
Americas
Asia
Europe
Oceania
856
(1%)
75,517
(57%)
24,762
(19%)
27,113
(21%)
3,300
(3%)

Overview of reported side effects



Blood and lymphatic system : 6,045
Cardiac : 5,290
Congenital and genetic disorders : 335
Ear and labyrinth : 1,289
Endocrine system : 1,702
Eye : 3,165
Gastrointestinal : 34,486
General disorders and administr. Site : 31,666
Hepatobiliary : 2,558
Immune system : 4,033
Infections and infestations : 3,826
Injury and poisoning : 10,926
Investigations : 7,634
Metabolism and nutrition : 5,802
Musculoskeletal and connective tissue : 7,778
Neoplasms : 2,680
Nervous system : 15,735
Pregnancy and perinatal conditions : 217
Product issues : 2,592
Psychiatric : 9,016
Renal and urinary tracts : 41,583
Reproductive system and breasts : 1,585
Respiratory and thoracic : 8,661
Skin and subcutaneous tissue : 20,622
Social circumstances : 439
Surgical and medical procedures : 1,200
Vascular : 4,153
Related drugs and vaccines